European Confederation of Pharmaceutical Entrepreneurs

EUCOPE

The European Confederation for Pharmaceutical Entrepreneurs (EUCOPE) is the voice of small to medium-sized innovative companies in the fields of pharmaceuticals, biotechnologies and medical devices.

Links

Website Transparency Register Profile

ID: 87600691525-93

Lobbying Activity

Meeting with Maya Matthews (Head of Unit Health and Food Safety) and European Federation of Pharmaceutical Industries and Associations

22 Oct 2025 · Exchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.

Meeting with Olivér Várhelyi (Commissioner) and

16 Oct 2025 · Situation of medium sized innovative pharma sector

Response to Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices as regards simplification and burden reduction

6 Oct 2025

Response to Regulation of the European Parliament and of the Council establishing a framework of measures for strengthening Europe’s innovation ecosystem

3 Oct 2025

Meeting with Olivér Várhelyi (Commissioner) and

2 Oct 2025 · All pressing portfolio topics

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur)

23 Sept 2025 · Critical Medicines Act

Response to Commission Communication on a EU Cardiovascular Health Plan

15 Sept 2025

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulations (EU) 2016/679, (EU) 2016/1036, (EU) 2016/1037, (EU) 2017/1129, (EU) 2023/1542 and (EU) 2024/573 as regards the extension of certain mitigating measures available for small and medium sized enterprises to small mid-cap enterprises and further simplification measures

28 Jul 2025

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directives 2014/65/EU and (EU) 2022/2557 as regards the extension of certain mitigating measures available for small and medium sized enterprises to small mid-cap enterprises and further simplifying measures

28 Jul 2025

Meeting with Angelika Niebler (Member of the European Parliament)

24 Jul 2025 · EU Health Care Policies

Meeting with Pascal Arimont (Member of the European Parliament)

14 Jul 2025 · APA Training on CBRN Threats

Meeting with Tomislav Sokol (Member of the European Parliament, Rapporteur)

9 Jul 2025 · Health policy

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

4 Jul 2025

Meeting with Ann-Sofie Ronnlund (Cabinet of Commissioner Ekaterina Zaharieva)

3 Jul 2025 · Life sciences

Meeting with Olivér Várhelyi (Commissioner) and

17 Jun 2025 · EU biotech policy

Meeting with Tilly Metz (Member of the European Parliament, Shadow rapporteur) and

13 Jun 2025 · Critical Medicines Act

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Strategy to support medical countermeasures against public health threats

8 May 2025

Response to Communication on the EU Stockpiling Strategy

8 May 2025

Meeting with Sirpa Pietikäinen (Member of the European Parliament)

8 May 2025 · Health security

Meeting with Laszlo Andrejko (Cabinet of Commissioner Olivér Várhelyi)

29 Apr 2025 · Biotech

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

17 Apr 2025

Meeting with Oliver Schenk (Member of the European Parliament)

3 Apr 2025 · Pharmaceutical Industry in the EU

Meeting with Maya Matthews (Head of Unit Health and Food Safety)

27 Mar 2025 · EU HTA regulation

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions: European Start-up and Scale-up Strategy

14 Mar 2025

Meeting with Tomislav Sokol (Member of the European Parliament) and Acumen Public Affairs

5 Mar 2025 · Health policy

Meeting with Andreas Glück (Member of the European Parliament)

4 Mar 2025 · Health

Response to Critical Medicines Act

27 Feb 2025

Meeting with Michalis Hadjipantela (Member of the European Parliament)

14 Jan 2025 · Introductory meeting

Meeting with Marc Lemaitre (Director-General Research and Innovation)

21 Nov 2024 · EUCOPE’s priorities and the perspective of the smaller innovative pharmaceutical industry

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 with regard to the procedures for joint scientific consultations on medicinal products for human use at Union level

23 Oct 2024

Meeting with Stine Bosse (Member of the European Parliament, Committee chair) and European Federation of Pharmaceutical Industries and Associations

15 Oct 2024 · European health policy

Meeting with Eszter Lakos (Member of the European Parliament) and Acumen Public Affairs

10 Oct 2024 · Life sciences industry

Meeting with Tiemo Wölken (Member of the European Parliament)

24 Sept 2024 · Generel exchange (staff level)

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devices

24 Jul 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2021/2282 of the European Parliament and of the Council as regards the management of conflicts of interest in the joint work of the Member State Coordination Group on Health Technology Assessment and its subgroups

26 Jun 2024

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

2 Apr 2024

Meeting with Elisabetta Gualmini (Member of the European Parliament)

19 Mar 2024 · Reform of the EU pharmaceutical legislation

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and Bayer AG

7 Mar 2024 · Directive on Medicinal products for human use

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur)

5 Mar 2024 · Revsion of Pharmaceutical package (staff level)

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Regulation (EC) No 1234/2008 as regards the examination of variations to the terms of marketing authorisations for medicinal products for human use

29 Feb 2024

Meeting with Stelios Kympouropoulos (Member of the European Parliament)

15 Feb 2024 · rare diseases

Meeting with Patrizia Toia (Member of the European Parliament)

7 Feb 2024 · Pharmaceutical package

Meeting with Frédérique Ries (Member of the European Parliament, Shadow rapporteur)

17 Jan 2024 · Revision of the Parmaceutical Legislation

Meeting with Frédérique Ries (Member of the European Parliament, Shadow rapporteur) and

5 Dec 2023 · Revision of the Pharmaceutical Legislation

Meeting with Dolors Montserrat (Member of the European Parliament) and Haleon

28 Nov 2023 · Revision of the pharmaceutical legislation

Meeting with Ondřej Knotek (Member of the European Parliament)

22 Nov 2023 · Pharmaceutical package

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and

22 Nov 2023 · Directive on Medicinal products for human use

Meeting with Frédérique Ries (Member of the European Parliament, Shadow rapporteur)

15 Nov 2023 · Revision of the Pharmaceutical Legislation

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur)

10 Nov 2023 · Pharmaceutical legislation

Meeting with Henna Virkkunen (Member of the European Parliament, Rapporteur for opinion) and

20 Oct 2023 · Medicinal products for human use

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur)

28 Sept 2023 · Pharmaceutical legislation

Response to Commission Delegated Regulation supplementing Directive 2001/83/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council on the examination of variations to the terms of marketing authorisations for medicinal products for human use and amending Commission Regulation (EC) No 1234/2008 of 24 November 2008

26 Sept 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

5 Sept 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

5 Sept 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the supplementary protection certificate for medicinal products (recast)

28 Jul 2023

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on compulsory licensing for crisis management and amending Regulation (EC) 816/2006

28 Jul 2023

Meeting with Sara Cerdas (Member of the European Parliament, Shadow rapporteur) and Standing Committee of European Doctors

7 Nov 2022 · Espaço Europeu de Dados de Saúde

Meeting with Sara Cerdas (Member of the European Parliament)

7 Nov 2022 · Legislação Farmacêutica

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on standards of quality and safety for substances of human origin intended for human application and repealing Directives 2002/98/EC and 2004/23/EC

7 Sept 2022

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the European Health Data Space

27 Jul 2022

Meeting with Giorgos Rossides (Cabinet of Commissioner Stella Kyriakides), Karolina Herbout-Borczak (Cabinet of Commissioner Stella Kyriakides)

18 May 2022 · Exchange of views on the upcoming reform of the pharmaceutical legislation

Response to Enhancing the coherence and effectiveness of compulsory licensing of patents in the EU, especially in crisis situations, including for export purposes to third countries

28 Apr 2022

Response to Proposal for a Regulation amending Regulations (EC) No 469/2009 and 1610/96 concerning supplementary protection certificates (SPCs) with a view to creating a unified granting procedure, and proposal for a Regulation creating a unitary SPC

4 Apr 2022

Response to Revision of Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC)

22 Feb 2022

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL LAYING DOWN HARMONISED RULES ON ARTIFICIAL INTELLIGENCE (ARTIFICIAL INTELLIGENCE ACT) AND AMENDING CERTAIN UNION LEGISLATIVE ACTS

29 Jul 2021

Meeting with Cyrus Engerer (Member of the European Parliament)

13 Jul 2021 · Pharmaceutical Strategy

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to Report from the Commission to the EP and Council on the operation and performance of the Directive 2011/24/EU on the application of patient rights in cross-border healthcare foreseen under Article 17(1) and Article 20(1) & (2) of Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011

11 Feb 2021

Response to Proposal for Regulation [tbc] on the European Health Data Space, digital health services and products and the use of new technologies, including artificial intelligence (AI) in health

3 Feb 2021

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Regulation (EC) No 851/2004 establishing a European Centre for disease prevention and control

1 Feb 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

6 Jan 2021

Response to Revision of Directive 2002/98/EC on safety and quality of human blood and blood components and of Directive 2004/23/EC on safety and quality of human tissues and cells and their implementing acts.

14 Dec 2020

Response to COMMISSION DELEGATED REGULATION (EU) …/... amending Annex II to Regulation (EC) No 2019/6 of the European Parliament and of the Council

8 Dec 2020

Meeting with Stella Kyriakides (Commissioner) and

6 Nov 2020 · Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic

Meeting with Stella Kyriakides (Commissioner) and

30 Sept 2020 · Call with pharmaceutical and medical device supply Chain on COVID-19

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions "Making the most of EU’s innovative potential - An Intellectual Property action plan in support of the EU’s industrial competitiveness"

13 Aug 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

6 Jul 2020

Meeting with Stella Kyriakides (Commissioner) and

29 Jun 2020 · Call with pharmaceutical and medical device industry associations on COVID-19

Meeting with Stella Kyriakides (Commissioner) and

29 Jun 2020 · Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic

Meeting with Stella Kyriakides (Commissioner) and

29 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

15 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and

8 May 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

Meeting with Thierry Breton (Commissioner) and

29 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

Meeting with Thierry Breton (Commissioner) and

23 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

17 Apr 2020 · Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Thierry Breton (Commissioner) and

9 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Stella Kyriakides (Commissioner) and

9 Apr 2020 · Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak

Meeting with Anne Bucher (Director-General Health and Food Safety)

3 Apr 2019 · Key aspects of current EU files related to health

Meeting with Anne Bucher (Director-General Health and Food Safety)

3 Apr 2019 · EUCOPE’s presentation and discussion about ongoing EU health files

Meeting with Vytenis Andriukaitis (Commissioner) and

15 Jun 2018 · HTA

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

7 Feb 2018 · Supplementary protection certificate; HTA

Response to Joint evaluation of Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products

8 Jan 2018

Response to COMMISSION REGULATION (EU) …/… amending Regulation (EC) No 847/2000 as regards the definition of the concept 'similar medicinal product'

27 Nov 2017

Meeting with Rolf Carsten Bermig (Cabinet of Commissioner Elżbieta Bieńkowska)

5 Oct 2015 · new off-lable rules in France

Meeting with Annika Nowak (Cabinet of Commissioner Vytenis Andriukaitis)

13 Apr 2015 · Off-label use of medicines